This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Meet our Guest Bloggers! This spring we’ve been quite fortunate to be joined by 6 Master’s students from Columbia University, who have been contributing to our creation of community resources as part of the
SATURDAY, March 9, 2024 -- Endometriosis causes crippling pain in women, with some spending up to a month of every year debilitated by it.“We’re talking about pain that’s beyond ‘I took two ibuprofen and went to work,’” said Dr. Kristin.
NASCOBAL (cyanocobalamin) Endo pharms inc Patent: 7,404,489 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com… The post Drug Patent Expirations for the Week of March 10, 2024 appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril… The post Drugs facing the most patent expirations this year appeared first on DrugPatentWatch - Make Better Decisions.
I don’t like testing Databricks notebooks and that’s a problem. I like Databricks. I like Test Driven Development. Not in an evangelical; 100% code coverage or fail kind of way. I just find that a reasonable amount of code coverage gives me a reasonable amount of confidence. Databricks has documentation for unit testing. I tried to test one notebook using another notebook.
I don’t like testing Databricks notebooks and that’s a problem. I like Databricks. I like Test Driven Development. Not in an evangelical; 100% code coverage or fail kind of way. I just find that a reasonable amount of code coverage gives me a reasonable amount of confidence. Databricks has documentation for unit testing. I tried to test one notebook using another notebook.
I don’t like testing Databricks notebooks and that’s a problem. I like Databricks. I like Test Driven Development. Not in an evangelical; 100% code coverage or fail kind of way. I just find that a reasonable amount of code coverage gives me a reasonable amount of confidence. Databricks has documentation for unit testing. I tried to test one notebook using another notebook.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content